Liver Inflammation and Hepato-Pancreatic Biliary Cancers (HPBCs)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 101
Special Issue Editor
Interests: liver inflammation; hepato-pancreatic biliary cancers; epidemiological aspects; basic aspects; clinical aspects
Special Issue Information
Dear Colleagues,
Chronic hepatitis virus infection (hepatitis B virus, HBV; hepatitis C virus, HCV) causes chronic inflammation in the liver, which greatly increases the risk of developing liver cancer (HCC). Chronic hepatitis infection causes genetic mutations in hepatocytes that progress to cancer via cirrhosis, as the latter causes liver cell fibrosis and promotes cancer development. There is also epidemiological evidence of chronic hepatitis inflammation increasing the risk of biliary tract cancers. For hepatitis and pancreatic cancer, common risk factors (e.g., alcohol consumption and obesity) have also been reported to increase risk. We would like to provide an update on the associations between liver inflammation and hepato-pancreatic biliary cancers (HPBCs) from epidemiological, clinical, and basic medical aspects.
Prof. Dr. Tsutomu Masaki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver inflammation
- hepato-pancreatic biliary cancers
- basic study
- clinical study
- epidemiological study
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
